- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Galapagos NV ADR (GLPG)
Assess today's live Galapagos NV ADR (GLPG) share price, performance and insights using our live NASDAQ: GLPG stock exchange data.
Analyse the historical data and Galapagos NV ADR share price performance charts on this page. Our technical summary section provides analysis on Galapagos ADR share price buy/sell indicators using real-time data (or discuss the Galapagos ADR (GLPG) stock price today with other investors in the Galapagos ADR NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ GLPG share price (ISIN: US36315X1019) to enhance your trading decisions with our free investment tools and resources.
What Is the Galapagos NV ADR Share Price Today?
The Galapagos ADR share price today is 32.94.
What Is the Stock Symbol for Galapagos NV ADR
The stock symbol (or 'ticker') for Galapagos NV ADR is "GLPG."
What Stock Exchange Does Galapagos NV ADR Trade On?
Galapagos NV ADR is listed and trades on the NASDAQ stock exchange.
Is Galapagos NV ADR a Good Stock to Buy?
Determining whether Galapagos NV ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Galapagos NV ADR share price performance charts on this page. Our technical summary section provides analysis on Galapagos ADR share price buy/sell indicators using real-time data (or discuss the Galapagos ADR (GLPG) stock price today with other investors in the Galapagos ADR NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ GLPG share price (ISIN: US36315X1019) to enhance your trading decisions with our free investment tools and resources.
What Is the Galapagos NV ADR Share Price Today?
The Galapagos ADR share price today is 32.94.
What Is the Stock Symbol for Galapagos NV ADR
The stock symbol (or 'ticker') for Galapagos NV ADR is "GLPG."
What Stock Exchange Does Galapagos NV ADR Trade On?
Galapagos NV ADR is listed and trades on the NASDAQ stock exchange.
Is Galapagos NV ADR a Good Stock to Buy?
Determining whether Galapagos NV ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
32.66
33.11
52 wk Range
22.36
37.78
GLPG is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
32.6633.11
52 wk Range
22.3637.78
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GLPG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
27.77
Downside
-15.70%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
5 analysts have revised their earnings upwards for the upcoming period
- Form 6K Galapagos NV ADR For: 18 December
- Investing.com
- Form 6K Galapagos NV ADR For: 18 December
- Investing.com
- Form 6K Galapagos NV ADR For: 8 December
- Investing.com
- Form 6K Galapagos NV ADR For: 26 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Galapagos ADR Company Profile
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Galapagos NV ADR Earnings Call Summary for Q3/2025
- Galapagos reported Q3 2025 EPS of -$0.4778 (35.39% miss) and revenue of $76.1M (4.84% miss), while stock rose slightly by 0.5% to $30.04 in premarket trading
- Company recorded a €462.2M operating loss for the first nine months, including a €204.8M cell therapy business impairment and €135.5M in strategic reorganization costs
- Despite financial challenges, Galapagos maintains a strong cash position of €3.05B (approximately €46 per share), supporting its focus on oncology and immunology
- Management forecasts becoming cash flow neutral to positive by end of 2026, while pursuing strategic partnerships, particularly with Gilead, to enhance its therapeutic pipeline
- Strategic reorganization includes winding down the cell therapy business, potentially affecting up to 365 positions, with management open to proposals during this process
Last Updated: 06/11/2025, 14:20
Read Full TranscriptCompare GLPG to Peers and Sector
Metrics to compare | GLPG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGLPGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.1x | 17.9x | −0.6x | |
PEG Ratio | 0.01 | 0.10 | 0.00 | |
Price/Book | 0.8x | 4.9x | 2.6x | |
Price / LTM Sales | 6.4x | 4.8x | 3.2x | |
Upside (Analyst Target) | −12.0% | 58.6% | 41.8% | |
Fair Value Upside | Unlock | 9.6% | 5.1% | Unlock |
Analyst Ratings
0 Buy
3 Hold
2 Sell
Ratings:
5 analysts
Overall Consensus
Sell
Analysts 12-Month Price Target:
Average 27.77
(-15.70% Downside)
Earnings
Latest Release
Nov 05, 2025
EPS / Forecast
-3.54 / -0.3529
Revenue / Forecast
82.12M / 79.97M
People Also Watch
FAQ
What Is the Galapagos ADR (GLPG) Share Price Today?
The live Galapagos ADR share price today is 32.94
What Stock Exchange Does Galapagos ADR (GLPG) Trade On?
Galapagos ADR is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Galapagos ADR?
The stock symbol (also called a 'ticker') for Galapagos ADR is "GLPG."
What Is the Current Galapagos ADR Market Cap?
As of today, Galapagos ADR market capitalisation is 2.16B.
What Is Galapagos ADR's (GLPG) Earnings Per Share (TTM)?
The Galapagos ADR EPS is currently -6.74 (Trailing Twelve Months).
When Is the Next Galapagos ADR Earnings Date?
Galapagos ADR's next earnings report will be released on 24 Feb 2026.
Is GLPG a Buy or Sell From a Technical Analyst Perspective?
Based on today's Galapagos ADR moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Galapagos ADR Stock Split?
Galapagos ADR has split 0 times. (See the GLPG stock split history page for full effective split date and price information.)
How Many Employees Does Galapagos ADR Have?
Galapagos ADR has 704 employees.
What is the current trading status of Galapagos ADR (GLPG)?
As of 24 Dec 2025, Galapagos ADR (GLPG) is trading at a price of 32.94, with a previous close of 32.48. The stock has fluctuated within a day range of 32.66 to 33.11, while its 52-week range spans from 22.36 to 37.78.
What Is Galapagos ADR (GLPG) Price Target According to Analysts?
The average 12-month price target for Galapagos ADR is USD27.76848799, with a high estimate of USD32.66368347 and a low estimate of USD22.06194065. 0 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Sell. The stock has an -15.70% Downside potential.
What Is the GLPG Premarket Price?
GLPG's last pre-market stock price is 33.04. The pre-market share volume is 2,340.00, and the stock has decreased by 0.56, or 1.72%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.